JungJ YYeonJ HRyuH SYounS WParkK CHuhC H. Disseminated superficial porokeratosis developed by immunosuppression due to rheumatoid arthritis treatment. J Dermatol2009; 36: 466–7.
2.
CallenJ P. Complications and adverse reactions in the use of newer biologic agents. Semin Cutan Med Surg2007; 26: 6–14.
3.
KanitakisJEuvrardSFaureMClaudyA.Porokeratosis and immunosuppression. Eur J Dermatol1998; 8: 459–65.
4.
StewartLHowatACoulsonI.Disseminated superficial porokeratosis secondary to immunosuppression induced by etanercept for extensive psoriasis. Arch Dermatol2010; 146: 1193–4.
5.
NaranjoC ABustoUSellersE M. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther1981; 30: 239–45.
